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Abstract
Background: Chagas disease affects around 18 million people in the American continent. Unfortunately, there is no
satisfactory treatment for the disease. The drugs currently used are not specific and exert serious toxic effects. Thus, there is
an urgent need for drugs that are effective. Looking for molecules to eliminate the parasite, we have targeted a central
enzyme of the glycolytic pathway: triosephosphate isomerase (TIM). The homodimeric enzyme is catalytically active only as
a dimer. Because there are significant differences in the interface of the enzymes from the parasite and humans, we
searched for small molecules that specifically disrupt contact between the two subunits of the enzyme from Trypanosoma
cruzi but not those of TIM from Homo sapiens (HTIM), and tested if they kill the parasite.
Methodology/Principal Findings: Dithiodianiline (DTDA) at nanomolar concentrations completely inactivates recombinant
TIM of T. cruzi (TcTIM). It also inactivated HTIM, but at concentrations around 400 times higher. DTDA was also tested on
four TcTIM mutants with each of its four cysteines replaced with either valine or alanine. The sensitivity of the mutants to
DTDA was markedly similar to that of the wild type. The crystal structure of the TcTIM soaked in DTDA at 2.15 A ˚ resolution,
and the data on the mutants showed that inactivation resulted from alterations of the dimer interface. DTDA also prevented
the growth of Escherichia coli cells transformed with TcTIM, had no effect on normal E. coli, and also killed T. cruzi
epimastigotes in culture.
Conclusions/Significance: By targeting on the dimer interface of oligomeric enzymes from parasites, it is possible to
discover small molecules that selectively thwart the life of the parasite. Also, the conformational changes that DTDA induces
in the dimer interface of the trypanosomal enzyme are unique and identify a region of the interface that could be targeted
for drug discovery.
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Introduction
Triosephosphate isomerase (TIM) is a ubiquitous enzyme that
catalyzes the interconversion between glyceraldehyde 3-phosphate
and dihydroxyacetone phosphate. In most of the species the enzyme
is formed by two identical monomers of approximately 250 amino
acids. TIM belongs to the family of a-b barrels proteins, in which 8
central b strands are surrounded by 8 a helices; the strands and
helices are joined by loops. It is one of the most thoroughly studied
enzymes.Itskineticsare wellestablished [1,2],the crystalstructure of
the enzyme from 15 different species is available, and significant
advances have been made on the dynamics of the enzyme when it is
in the resting state and during active catalysis [3–5].
A peculiarity of TIM is that only in its dimeric form the enzyme
exhibits high catalytic rates, albeit each monomer has its own
catalytic residues [6–8]. Along this line, it has been reported that
deletion of some residues of loop3 in TIM from Trypanosoma brucei
(TbTIM), which forms an important portion of the interface,
yields a monomeric enzyme with drastically reduced catalytic
activity [9,10]. Likewise, it has been shown that chemical
perturbation by thiol reagents of the interfacial Cys15 of TbTIM,
and that of TIMs from T. cruzi (TcTIM), Leishmania mexicana
(LmTIM) [11], Plasmodium falciparum [12], and Entamoeba histolytica
[13] induces drastic changes in the quaternary and tertiary
structure of the respective dimers and abolition of catalytic activity.
The latter observations raised the question as to whether agents
that interfere with protein-protein interactions in either permanent
of transient oligomers, could be exploited for the discovery of
molecules with pharmacological potential [14,15]. From the point of
view of drug discovery for diseases that are caused by parasites, the
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evolution the catalytic site of enzymes has been largely conserved,
whereas the amino acids that form the interfaces of oligomeric
enzymes have undergone significant changes [16–18]. For example,
TIMs from human and the aforementioned parasites have the same
catalytic residues; in contrast, the identity of the approximately 32
interfacial residues of TIM from either of the parasites and human is
approximately 52%, whereas the identity of the amino acid residues
of the interface of the enzymes from T. cruzi, T. brucei and L. mexicana
is approximately 82% [8,15]. Therefore, it is theoretically possible to
find molecules that exhibit a high specificity for the interface of
oligomeric enzymes from parasites. Based on the amino acid
composition and structural differences of the interfaces of TIM, we
havefoundagentsthatbyactingonthedimerinterfaceexhibitahigh
specificity for TIM from parasites [15].
In our attempts to find more effective low molecular weight
compounds, we synthesized 3-(2-benzothiazolylthio)-1 propa-
nethioaniline. We found that it induced a strong inhibition of
enzyme activity. However, subsequent studies showed that the
inhibition was not due to this compound, but to a contaminant
that formed during its preparation. This proved to be 2,29-
dithiodianiline, (DTDA). Here we describe the action of DTDA
on the function and structure of TcTIM. The compound is highly
selective for TcTIM. We also found that DTDA inhibited the
growth of Escherichia coli that had been transformed with TcTIM,
and that in the low micromolar range, the compound also caused
the death of T. cruzi epimastigotes. The crystal structure of the
enzyme treated with DTDA complex showed that it induced
important and rather unique alterations of the dimer interface.
Materials and Methods
TcTIM [19] and TIMs from T. brucei [20], L. mexicana [21], and
Homo sapiens [22] were expressed in Escherichia coli and purified as
described in the indicated references. After purification, the
enzymes dissolved in 100 mM triethanolamine, 10 mM EDTA
and 1 mM dithiothreitol (pH 8) were precipitated with ammoni-
um sulfate (75% saturation) and stored at 4uC. Before use, the
enzymes were extensively dialyzed against 100 mM triethanola-
mine/10 mM EDTA (pH 7.4). Protein was determined from their
absorbance at 280 nm [23]. The e M
21 cm
21 was 36440 for
TcTIM, and 33460 for TbTIM and LmTIM.
Synthesis of 2,29-dithiodianiline (DTDA)
A solution of 1 g of 2-aminothiophenol in 10 ml dichloro-
methane was stirred at room temperature for 8 h to promote its
oxidation. The residual material was washed with hexane and
purified by silica gel chromatography with dichloromethane as
eluent to give 0.97 g of DTDA. The product was characterized by
mass spectrometry and NMR analysis. DTDA is spontaneously
formed from 2-aminothiophenol and its reactivity is typical of
disulfides. Its reaction with sulfides, such as cysteine, yields a mixed
disulfide (Fig. 1). Indeed, as shown in the Results section, we found
that Cys118 of wild type TcTIM reacts with DTDA forming
a disulfide bond between Cys118 and thioaniline. The reaction
would be analogous to the standard opening of disulfide bridges by
reaction with an excess of b-mercaptoethanol or dithiothreitol.
In all the experiments, a solution of DTDA in dimethylsulfoxide
(DMSO) was used. The final DMSO concentration in all
experiments was 10% (v/v). It is noted that that at this
concentration, DMSO did not affect the activity of the enzymes
that were used.
Assay of the action of DTDA on the various TIMs
The indicated TIMs were incubated at pH 7.4 at a concentra-
tion of 5 mg per ml of 100 mM triethanolamine, 10 mM EDTA,
10% dimethyl sulfoxide (v/v), and DTDA at the concentrations
indicated in the Results section for 2 hours at 36uC. At this time,
an aliquot was withdrawn for assay of activity.
Activity
Activity was determined in the direction of glyceraldehyde 3-
phosphate to dihydroxyacetone phosphate [11]. The decrease in
absorbance at 340 nm was followed in a Hewlett Packard
spectrophotometer at 25uC. The reaction mixture (1 ml) con-
tained 100 mM triethanolamine, 10 mM EDTA, 0.2 mM
NADH, 1 mM glyceraldehyde 3-phosphate, and 0.9 units a-
glycerolphosphate dehydrogenase (pH 7.4). The reaction was
started by the addition of TIM, usually 5 ng. The average specific
activity of the various preparations of TcTIM used in this work
was 29006200 mmol/min/mg.
Author Summary
Most of the enzymes of parasites have their counterpart in
the host. Throughout evolution, the three-dimensional
architecture of enzymes and their catalytic sites are highly
conserved. Thus, identifying molecules that act exclusively
on the active sites of the enzymes from parasites is
a difficult task. However, it is documented that the
majority of enzymes consist of various subunits, and that
conservation in the interface of the subunits is lower than
in the catalytic site. Indeed, we found that there are
significant differences in the interface between the two
subunits of triosephosphate isomerase from Homo sapiens
and Trypanosoma cruzi (TcTIM), which causes Chagas
disease in the American continent. In the search for agents
that specifically inhibit TcTIM, we found that 2,29-dithioani-
line (DTDA) is far more effective in inactivating TcTIM than
the human enzyme, and that its detrimental effect is due
to perturbation of the dimer interface. Remarkably, DTDA
prevented the growth of Escherichia coli cells that had TcTIM
instead of their own TIM and killed T. cruzi epimastigotes in
culture. Thus, this study highlights a new approach base of
targeting molecular interfaces of dimers.
Figure 1. Reaction of DTDA with cysteine. The reaction of DTDA with the thiol group of Cys could be favored by the formation of an
intramolecular hydrogen bond and the inductive effect of the amino group due to the higher electronegativity of the nitrogen atom with respect to
the sulfur atom.
doi:10.1371/journal.pntd.0000001.g001
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E. coli JM103 cells were used as control. E. coli devoid of their
endogenous TIM termed VR101 [10] were kindly provided by Dr.
Gloria Saab-Rinco ´n; these cells have a kanamicin resistant cassette.
The latter cells were transformed with the plasmid pTrc99aTc-
TIM that had an ampicilin resistant cassette. The strains were
grown at 37uC in solid Luria-Bertani medium that had been
supplemented with 50 mg of kanamycin and 50 mg of ampicilin
per ml. One colony was transferred to M9 medium that had 10%
DMSO and 50 mg of each of the latter antibiotics per ml. Growth
of the various cells was followed throughout time by measuring the
absorbance of the culture at 600 nm.
Culture of parasites
To study the effect of DTDA on the T. cruzi,1 0
6 epimastigotes
of the strain ninoa were inoculated into RPMI 1640 media
supplemented with 10% fetal bovine serum (Gibco, BRL,
Rockville, Md); the media also had 10% DMSO (v/v); at this
concentration DMSO did not exert a detrimental effect on the
growth of E. coli cells, nor on the growth and survival of T. cruzi
epimastigotes. Where indicated in the Results section, the media
was supplemented with the indicated concentrations of DTDA.
The number of cells was recorded at various times for as long as
72 hours.
Soaking of TcTIM crystals with DTDA and data collection
We attempted to co-crystallize TcTIM with DTDA; we tried
different concentrations of enzyme and DTDA, but all our
attempts were unsuccessful. However, we succeeded in obtaining
crystals of the complex by soaking crystals of TcTIM with DTDA.
TcTIM was crystallized by the vapor diffusion hanging drop
method. TcTIM, 2.5 mgi n5 ml of 25 mM triethanolamine
(pH 8.0) was mixed with 5 ml of reservoir solution (0.1 M Na-
Hepes, pH 7.5, 2% (v/v) PEG 400, and 2.0 M ammonium
sulfate). Crystals appeared after two or three weeks. At this time,
1 ml of 10 mM DTDA was added to the drop (1 mM final
concentration). After 48 hours the crystal was transferred to
a cryoprotectant solution (30% (v/v) glycerol) and flash frozen.
Diffraction data were collected at 113 K with a Rigaku X-ray
rotating anode generator and an R-Axis IIC image plate detector.
The data was processed and scaled with d*TREK [24].
Structure determination and refinement
The 3D structure was solved using molecular replacement
with the program MOLREP [25] and the coordinates of native
TcTIM (PDB code 1TCD) as the search model. Refinement was
carried out first with the program CNS [26], and manual
adjustments of the model into electron density maps were done
using QUANTA2000 (Accelrys). Five percent of the reflections
were set aside for validation. The anisotropic motion of the
subunits was described with the TLS parameters as implemented
in REFMAC5 [27]. Both the molecular replacement and TLS
refinement of the structure were done using the CCP4 program
suite version 5.2.0005 [28]. A summary of the data-collection and
refinement statistics is given in Table I. The coordinates of the
structure have been deposited in the Protein Data Bank (PDB code
2OMA).
Results
As noted, we found that a contaminant that formed during the
synthesis of 3-(-2-benzothiazolylthio)-1 propanethioaniline was
a powerful inhibitor of the activity of TcTIM. The contaminant
was identified as 2,29-dithiodianiline (DTDA). The compound was
subsequently synthesized, and the product characterized by mass
spectrometry and NMR analysis. When the effect of DTDA was
assessed in TIMs from various sources (Fig. 2), it was found that
260 nM induced 50% inhibition of the activity of TcTIM, and
that 10 mM did not affect the activity of TbTIM, LmTIM and
TIM from H. sapiens (HTIM). In connection to the inhibiting effect
of DTDA on TcTIM, it is pointed out that the inhibition of
activity was accompanied by aggregation of the enzyme, indicating
that the compound induced drastic structural alterations. It is also
noted, that at concentrations higher than those used in the
experiment of Table 1, DTDA affected the activity of HTIM. Fifty
percent inhibition of HTIM activity was achieved with 98 mM
DTDA; thus, the selectivity for TcTIM in reference to HTIM is
nearly 400-times. It is also noteworthy that TbTIM and LmTIM
were completely insensitive to DTDA concentrations as high as
200 mM.
Since the three trypanosomatidal TIMs are very similar in
amino acid sequence and three-dimensional structure [29–31], it
was considered of interest to ascertain the mechanism through
which DTDA affects the activity of TcTIM. In a first approach,
we determined if the action of DTDA on TcTIM is related to the
presence of the disulfide bond between the two aniline moieties.
Accordingly, we synthesized and examined the action of 1,19-
(methylenebisthioaniline). In this compound the two aniline
moieties are joined by –S-C-S- bonds. In contrast to DTDA
which induces half-maximal inhibition at a concentration of
260 nM, 50 mM of 2,29-(methylenebisthioaniline) was required to
inhibit the activity of TcTIM by 50%. Clearly, the existence of the
disulfide bond is central for optimal detrimental actions of DTDA.
Because disulfide compounds can induce the thioalkylation of
free –SH groups, we assessed if the action of DTDA is related to the
cysteine content of the trypanosomatid enzymes. The three
enzymes have three common cysteines, those at positions 15, 41
and 127 (numbering system of TcTIM); TcTIM and LmTIM have
an additional cysteine at position 118. Thus, in a first approach, we
Figure 2. Effect of DTDA on the activity of TIMs from T. cruzi,
T. brucei, L. mexicana and Homo sapiens. The enzymes were incubated
at a concentration of 5 mg/ml in media that contained 100 mM
triethanolamine, 10 mM EDTA, 10% DMSO (v/v) and the indicated
concentrations of DTDA. After two hours of incubation at 36uC, aliquots
were withdrawn for assay of activity. 100% corresponds to the activity of
TcTIM, TbTIM, LmTIM, and human TIM at time zero; these activities were
2950, 3125, 4560, and 4900 mmol/min/mg, respectively.
doi:10.1371/journal.pntd.0000001.g002
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Cys118 was replaced by Val, the residue that exists in TbTIM. It
was reasoned that if the deleterious action of DTDA on wild type
TcTIM was due to perturbation of Cys118, the activity of the
C118V mutant would be insensitive to DTDA. However, we found
that the susceptibilities of the mutant and wild type enzymes to
DTDA were almost identical (Table 2). This indicates that Cys118
of TcTIM does not play a central role in the inhibition of TcTIM
by DTDA. These data are in consonance with the lack of effect of
DTDA on LmTIM which has a cysteine inposition 118.Moreover,
we found that a mutant of TbTIM in which its Val118 was
replaced by Cys was also insensitive to 200 mM DTDA (Table 2).
Collectively, these data indicate that the detrimental action of
DTDA on TcTIM does not depend on Cys118.
As noted the three-dimensional structure of TcTIM, TbTIM,
and LmTIM are strikingly similar. Of particular interest is that in
the three enzymes the side chain of Cys15 of each of the two
monomers is surrounded by residues of loop3 of the adjoining
subunits. It is also relevant that in the three enzymes, the
geometrical arrangements of the residues of loop3 around Cys15
in TcTIM and TbTIM are markedly similar. Regardless of the
similarities, the susceptibility of Cys15 of TcTIM to thiol reagents,
such as dithionitrobenzoic acid and methylmethane thiosulfonate, is
about two orders of magnitude higher than in TbTIM and LmTIM
[11]. Apparently, this is related to the higher intrinsic flexibility of
TcTIM [32]. Thus, we studied if the existence of Cys15 in TcTIM
was instrumental in the action of DTDA. To this end, we deter-
mined the susceptibility of a C15A mutant of TcTIM to DTDA.
The results showed that C15A TcTIM exhibited only a slightly
lower sensitivity (Table 2). Therefore, the data on the TcTIM
mutants indicate that the existence of cysteines, either at positions
15 or 118 is not necessary for the detrimental action of DTDA.
The effect of the compound was also studied in C127A and
C40A TcTIM mutants. The results showed that the C127A
mutant was more sensitive to DTDA than the wild type (Table 2).
It has been previously shown that the C127A mutation decreases
the stability of the enzyme [33]; thus, it is likely that the higher
sensitivity to DTDA is related to its lower intrinsic stability.
Nonetheless, the data with the C127A mutant indicate that
Cys127 is not involved in the detrimental action of DTDA
(Table 2). The effect of the compound was also assayed on the
C40A mutant. Similarly to the wild type, the activity of this mutant
was inhibited by about 50% by nM DTDA concentrations,
however, it was also observed that much higher concentrations
were needed to induce full inhibition of activity. The reasons for
this biphasic response are not clear.
X-ray structure of TcTIM soaked in DTDA
To gain insight into the mechanism through which DTDA
affects TcTIM, we attempted to co-crystallize the enzyme in
complex with DTDA, however, our efforts were unsuccessful. On
the other hand we were able to obtain crystals of the complex by
soaking crystals of TcTIM with 1 mM DTDA. The statistics of
data collection, reduction and refinement are shown in Table 1.
The general structure of the dimer was not altered by soaking with
DTDA (Fig. 3, A) (Accession Number PDBI code 2OMA). The
RMS deviation of the Ca traces of native TcTIM and the DTDA
treated enzymes was 0.39 A ˚. The data also showed that in the
position of Cys118, which is far from the interface, the two
monomers exhibited electron densities that fitted well with
a structure in which the sulfur of Cys118 was covalently linked
through a disulfide bond to a thioaniline moiety (Fig. 3, A and
B).Thus, in TcTIM crystals, DTDA was able to derivatize Cys118;
however, as shown by the data on the Cys118Val mutant, the
inhibition of activity by the compound does not depend on the
perturbation of Cys118.
Accordingly, and in regard to the inhibition of activity of
TcTIM by DTDA, it is relevant that the enzyme soaked with
DTDA exhibited significant and rather unique alterations in its
dimer interface. One of the most notable was that although loop3
of monomer B exhibited a conformation almost identical to that in
native TcTIM, loop3 of monomer A acquired a markedly different
conformation (Fig, 4, A). Loop3 of TcTIM is formed by residues
66–79 (Q, N, A, I, T, R, S, G, A, F, T, G, E, and V). In monomer
A of the DTDA treated enzyme, residues 66 to 70 and residues 77
to 79 superpose quite well with those of the ‘‘normal’’ loop,
however, the region formed by residues 71 to 76 exhibited
a significant displacement (Fig. 4, A) with a hinge at the level of
Table 1. Data Collection and Reduction Statistics for DTDA
treated TcTIM.
Data collection and reduction
Space group P212121
Unit cell dimension (A ˚) a=43.21, b=75.34, c=146.43
Total number of reflections 82720
Unique reflections 23141
Resolution (A ˚) 2.15
Completeness (%) 91.0
Rmerge (%) 9.3
Vm (A ˚3.Da
21)2 . 3
Redundancy 3.4
Refinement
Protein atoms/ligand atoms/water molecules 3850/92/268
Modified Cys residues with DTBA 2 (C118A and C118B)
Resolution range for refinement (A ˚) 41.45–2.15
Number of reflections (refinement) 23141 (1248 Rfree)
R/Rfree 0.197/0.250
RMS deviation (bond/angle/torsion) 0.022 A ˚/1.9u/18.5u
R=S|Fo-Fc|/SFo, summed over all hkl’s
doi:10.1371/journal.pntd.0000001.t001
Table 2. Concentrations of DTDA that induces 50% inhibition
in TcTIM and some of its mutants.
Enzyme IC50 (mM)
TcTIM wild 0.25860.035
TcTIM C118V 0.20860.037
TbTIM V118C NE
LmTIM NE
TcTIM C15A 0.34660.032
TcTIM C40A* 1.53260.450
TcTIM C127A 0.05760.0080
The effect of DTDA on the indicated enzymes was determined as in Figure 1,
from the data the concentration that induced half-maximal inhibition was
calculated. NE indicates that 200 mM DTDA had no effect.
*As noted in the text, relatively low DTDA concentrations inhibit the activity by
approximately 50%; significantly higher concentrations were required for full
inhibition. The data in the Table indicate the concentration at which half-
maximal inhibition of the initial phase was achieved.
doi:10.1371/journal.pntd.0000001.t002
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monomers A and B adopted in the DTDA treated TcTIM are
clearly evident in a superposition of the two (Fig. 4, A).
The change in conformation of loop3 of monomer A was
accompanied by alterations in the contacts that it establishes with
residues of monomer B. In native TcTIM, the side chain of Cys15
of the two subunits is well defined, and their N and O atoms are
respectively, hydrogen bonded to the O and N atoms of Gly73 of
the adjacent subunit (Fig. 4, B). In the DTDA treated enzyme,
these H-bonds are missing (Fig. 4, C). This was consequence of an
increase in the distance between Gly73 of monomer A and Cys15
of the other subunit; in the treated enzyme, the distances between
N and O atoms of Gly73 and the O and N atoms of Cys15 were
7.9 and 9.2 A ˚, respectively. It is noted that the crystallographic
data showed a negative electron density in the region of Cys15 of
monomer B (Fig. 3, C). Taken together, the data indicate that the
interactions of Cys15 of monomer B with Gly73 of the other
subunit are less stable than in the wild type, and thus in all
likelihood the inhibition of activity of TcTIM by DTDA is related
to the alterations of the dimer interface. Along this line, it is also
relevant that the B factors of residues 15 to 21 of monomer B in
DTDA treated TcTIM had an average of 42.66 A ˚ 2, whereas in
monomer A, the average values of the B factors of these same
residues were 29.48 A ˚ 2. In native TcTIM, the average B factors of
monomers A and B were 21.77 and 24.82 A ˚ 2, respectively.
Effect of DTDA on E. coli that had TcTIM instead of their
own TIM
In view of the powerful specific inhibiting effect of DTDA on
TcTIM, we considered important to ascertain if the compound is
able to cross biological membranes and whether it is detrimental to
cells that rely on the presence of TcTIM. Accordingly, we
determined the effect of the compound on E. coli cells that
possessed their own TIM and in cells that depended on the
function of TcTIM. These experiments involved three types of
cells: i) Cells that have their endogenous TIM, ii) E. coli that lack
their TIM, and iii) E. coli devoid of endogenous TIM that were
transformed with TcTIM. Figure 5A shows the growth curve of
intact cells in minimal media; the figure also shows that the growth
of cells that are devoid of TIM is almost nil. These data therefore,
Figure 3. A. Overall structure of the TcTIM soaked in DTDA. B.
Cysteine 118 is covalently bound to thiobenzylamine. Panel A
shows that the general structure of the TcTIM dimer is not altered by
DTDA; monomers A and B are shown in green and blue, respectively
and thioaniline in orange. The figures were prepared with PyMOL. In
panel B, the derivatized Cys118 of monomer B is shown. FoFc map (3 s)
after the first refinement using CNS annealing and B refinement; a clear
positive density that corresponds to covalently bound thioaniline is
observed. The same data were observed in monomer A (not shown).
doi:10.1371/journal.pntd.0000001.g003
Figure 4. Structural alterations of the interfacial Cys15-loop3
regions of TcTIM induced by the soaking with DTDA. Panel A
shows the superposition of loop3 of monomers A and B of the TcTIM
crystal soaked with DTDA. It depicts the large scale difference in the
conformations of loop3 of the ‘‘normal’’ monomer (B, in blue), and the
‘‘open’’ loop3 of monomer A (in green) in the span of residues 70–76.
The hinge residues T70 and T76 are colored in orange. Panel B shows
the interface region formed by Cys15 of monomer B and loop3 of the
other monomer in native TcTIM. Panel C shows the same region in the
DTDA treated enzyme. Please note that in native TcTIM, Cys15 is well
defined, and that it establishes two H-bonds with Gly73 of the adjacent
subunit (black dashed lines). These H-bonds do not exist in the DTDA
treated enzyme. Electron density maps are included (2Fo-Fc, 1s in blue
and Fo-Fc, -3s red), showing instability of Cys 15B.
doi:10.1371/journal.pntd.0000001.g004
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this respect it is particularly relevant that the growth of the latter
cells was restored when they were transformed with TcTIM (Fig. 5.
A), albeit the lag that precedes logarithmic growth was longer.
Thus, the experiments show that the endogenous TIM of E. coli
can be successfully replaced by the enzyme from T. cruzi.
When the effect of DTDA was assayed on the growth of normal
and TcTIM transformed E. coli, it was found that 30 mM of the
compound had no effect on cells that worked with their own TIM
(Fig. 5, B). On the other hand, the growth of cells that relied on the
function of TcTIM was effectively prevented by 30 mM DTDA
(Fig. 5, C), and that concentrations as low as 4 mM induced an
important increase in the lag that precedes logarithmic growth.
Clearly, the data indicate that biological membranes are perme-
able to DTDA and that it can inhibit the activity of intracellular
TcTIM.
Effect of DTDA on cultured T. cruzi epimastigotes
The latter data prompted us to study the effect of DTDA on
intact T. cruzi. To this end, 2 ml of RPM media that contained
different concentrations of the compound were inoculated with
10
6 T. cruzi epimastigotes, and incubated for 72 hours. The
number of cells in the culture was determined every 24 hours. It
was observed that at concentrations higher than 8 mM the
compound brought about a significant decrease in the number
of cells (Fig. 6). At lower concentrations (4 mM), DTDA brought
about inhibition of growth. Thus, depending on its concentration,
the compound, either prevented cell growth or caused the death of
T. cruzi epimastigotes.
We would like to point out that there is a difference on the
concentrations of DTDA that are effective on the pure enzyme
and in whole cells. The former is inhibited by nM concentrations,
whereas the adverse effects of the compound on TcTIM trans-
fected E. coli and epimastigotes are observed with concentrations
that are about 10 times higher. It is possible that in vivo, the binding
of DTDA to the proteins that exist in the intracellular milieu,
reduces its effective concentration. Although this phenomenon has
been well documented for some pharmacological agents [34], at
the moment it is not possible to offer a precise explanation for the
difference in effectiveness of DTDA in vitro and in whole cells.
Discussion
DTDA is a powerful inhibitor of the activity of TIM from T.
cruzi. It is also effective in human TIM, but at concentrations that
Figure 5. Growth of intact E. coli, of cells that lacked their
endogeous TIM, and of E. coli cells in which their endogenous
was replaced with TcTIM. Effect of DTDA. A shows the growth of
intact E. coli (closed squares), E. coli whose TIM had been deleted
(closed circles), and E. coli transformed with TcTIM (open triangles).
Panel B depicts the growth curves of intact E. coli with and without
30 mM DTDA (closed squares and open circles, respectively). Panel C
shows the growth curves of E. coli cells that had TcTIM instead of their
own TIM with the indicated concentrations of DTDA.
doi:10.1371/journal.pntd.0000001.g005
Figure 6. Effect of DTDA on T.cruzi epimastigotes. The parasites
were cultured as described under Material and Methods with the
indicated concentrations of DTDA.
doi:10.1371/journal.pntd.0000001.g006
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affect the activity of TIM from T. brucei, and L. mexicana, albeit
these enzymes are markedly similar to TcTIM in amino acid
sequence and three-dimensional structure. An additional salient
property of DTDA is that it is able to cross biological membranes
as evidenced by the data with E. coli. These experiments also
showed that DTDA does not affect the growth of intact E. coli,
whereas in cells that depend on the function of TcTIM, low
micromolar concentrations induce a strong inhibition of cell
growth. These findings thus indicate that cell membranes are
permeable to DTDA and that it affects adversely the life of cells
that depend on the function of TcTIM. In consonance with these
data, it was found that at concentrations of 4–8 mM, the
compound induces a significant inhibition of the growth of T.
cruzi epimastigotes, and that 10 mM and 15 mM causes death of
parasites in cell cultures. Although the overall data suggest that the
detrimental effect of DTDA on intact T. cruzi parasites is due to
inhibition of the activity of their TIM, the results do not prove
unambiguously that death of the parasites is due exclusively to the
inhibition of that enzyme.
In regard to the properties of DTDA, it is relevant to point out
that its effect and that of similar molecules on rodents have been
previously reported. For example, it has been reported that the
administration of 4,49-diamino disulfide to rats induces hemato-
logical alterations [35], and that DTDA brings about irreversible
oxidation of hemoglobin [36]; likewise, it was shown that
diaminodiphenyldisulfide causes necrotic changes in the liver,
and atrophy and hyperplasia in the kidney [37]. Although some
disulfides, such as the ethanol deterrent disulfiram [38,39] have
been successfully used for a long time as therapeutic agents, the
observations on the toxicity of DTDA and similar molecules
suggest that per se, this compound has no therapeutic value.
However, the specific action of DTDA on TcTIM and the unique
alterations that it induces in the structure of the enzyme suggest
that it can be used as lead for the discovery of agents with
pharmacological potential.
The experiments with pure recombinant wild type TcTIM and
the mutants in which each of the four Cys was replaced with Val
for the case of Cys118 or Ala in the other three Cys showed that
regardless of their cysteine content, the four enzymes exhibit
similar sensitivities to DTDA. Thus, it would appear that derivati-
zation of cysteines is not the primary event in the inhibition of
enzyme activity. On the other hand, the x-ray structure of native
TcTIM that had been soaked in DTDA revealed that it induces
important structural alterations of the dimer interface; the most
obvious was on the interactions of loop3 of monomer A with the
neighboring residues of the other subunit. Along this line, it is
relevant to point out that because of its importance in catalysis and
stability of the dimer, loop3 and its connections with the other
subunit have been extensively studied. For example, it has been
reported that perturbations of the interface region formed by
Cys15 and loop 3 of the other monomer induce inhibition of
activity [11–13]. In this connection it is relevant that Brown and
Kollman [40] and Aqvist and Fothergill [41] showed by molecular
modeling that during catalysis, the hydrogen bond of Thr76 of
loop3 with the catalytic His96 of the other subunit shifts to the
catalytic Glu. According to the authors, these arrangements are
essential for the expression catalytic activity. Thus, it is noteworthy
that the change in conformation of loop3 of monomer A had
a hinge that localized to Thr76.
In connection to the contribution of loop3 to the stability of
TIM dimers, it has been reported that deletions of some of the
residues of loop3, yield enzymes that essentially exist in the
monomeric form [9,10]. It is also relevant that the residues of
loop3 surround the side chain of Cys15 of the other monomer, and
that alkylation of the two interface Cys15 of P. falciparum [12] and
E. histolytica [13] by thiol reagents induces the formation of stable
monomers. In TIMs from T. cruzi and T. brucei, the derivatization
of their two interface Cys15 induces aggregation of the enzymes
[11]. In addition it is noteworthy that in a hybrid formed by
a C15A TcTIM monomer and a monomer of wild type TbTIM,
the alkylation of the only interface cysteine yields an enzyme that
conserves its dimeric structure, albeit its catalytic properties are
reduced by about one-half [42]. Therefore, it is mechanistically
important that in the DTDA treated enzyme, loop3 of monomer
A acquired a different position. This conformational change was
accompanied by alterations of the contacts of Cys15 with the
adjacent subunit; specifically, the electron density that corresponds
to the b-carbon of Cys15 was not apparent, whereas that of the
sulfur atom appeared diffuse. Moreover, DTDA treatment
induced the loss of two H-bonds in the Cys15-loop3 interfacial
region. The sum of these structural effects most likely accounts for
its inhibiting effect of DTDA on the activity of TcTIM.
In the crystallographic data, there is another point that merits
comment. This concerns the observation that even though in the
TIM dimer, there are two equivalent Cys15-loop3 regions, only
one of them was altered by DTDA, the other appeared intact. In
solution the inhibiting effect of DTDA is accompanied by enzyme
aggregation. This is in consonance with previous data [11] that
showed that alterations of the dimer interface by chemical
modification or site directed mutagenesis led to enzyme aggrega-
tion, indicating that perturbation of the interface lead to formation
of unstable monomers that subsequently undergo aggregations.
Therefore, it is likely that in the crystal, an intermediate of the
overall conformational changes induced by DTDA was trapped.
In sum, this work shows that DTDA specifically inhibits the
activity of TIM from T. cruzi, that it is able to cross biological
membranes, and that it is effective in T. cruzi epimastigotes. An
additional characteristic of DTDA is that it inhibits TcTIM by
perturbing the interactions between its two subunits; thus, this
compound is another example of the relatively small number of
the so far reported agents that by acting on protein-protein
interfaces induce a desired detrimental effect. Since the interfaces
of oligomeric proteins would seem to be excellent targets for the
discovery of agents that are specific for the enzymes from parasites
[14,15], DTDA would seem to be a good model for the discovery
of molecules that are less toxic, but that still conserve their
effectiveness in the T. cruzi enzyme.
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